Overview

Obese Patients With or Without Comorbidities (RIO-North America)

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbidities
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Rimonabant